Cav3.2 Protein (T Type Calcium Channel Alpha 1H) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Cav3.2 Protein (T Type Calcium Channel Alpha 1H) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
CACNA1H encodes the alpha-1H subunit of low-voltage-activated T-type calcium channels (Cav3.2).
Cav3.2 Protein (T Type Calcium Channel Alpha 1H) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cav3.2 Protein (T Type Calcium Channel Alpha 1H) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. Voltage-gated calcium channels. Pharmacological Reviews. 2005. ↩︎